SELLAS Life Sciences Group, Inc. — Director's Dealing 2021

Dec 3, 2021

SEC Form 4/A — Form 4/A

Issuer: SELLAS Life Sciences Group, Inc. (SLS)
CIK: 0001390478
Period of Report: 2020-03-12

Reporting Person: Stergiou Angelos M. (Director, President and CEO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	103537	Direct

Footnotes

F1: This amended Form 4/A is being filed to correct a mathematical error in Column 5 of the original Form 4 filed on March 16, 2020 regarding the amount of securities beneficially owned by the Reporting Person following the transaction. As a result of the mathematical error in Column 5 of the original Form 4 filed on March 16, 2020, Column 5 of the Form 4 filed on March 8, 2021 was incorrect and should have reflected an amount of 123,287.